Sai Yendamuri

9.5k total citations · 1 hit paper
161 papers, 7.0k citations indexed

About

Sai Yendamuri is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Sai Yendamuri has authored 161 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Pulmonary and Respiratory Medicine, 49 papers in Molecular Biology and 42 papers in Oncology. Recurrent topics in Sai Yendamuri's work include Lung Cancer Diagnosis and Treatment (60 papers), Lung Cancer Treatments and Mutations (31 papers) and Pleural and Pulmonary Diseases (25 papers). Sai Yendamuri is often cited by papers focused on Lung Cancer Diagnosis and Treatment (60 papers), Lung Cancer Treatments and Mutations (31 papers) and Pleural and Pulmonary Diseases (25 papers). Sai Yendamuri collaborates with scholars based in United States, Italy and Japan. Sai Yendamuri's co-authors include Carlo M. Croce, George A. Calin, Cinzia Sevignani, Florencia Bullrich, Masayoshi Shimizu, Massimo Negrini, Terry Hyslop, Calin Dan Dumitru, Evan Noch and Todd L. Demmy and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Sai Yendamuri

153 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

2004 3.3k citations George A. Calin, Cinzia Sevignani et al. profile →

Peers

Countries citing papers authored by Sai Yendamuri

Since Specialization

Citations

This map shows the geographic impact of Sai Yendamuri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sai Yendamuri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sai Yendamuri more than expected).

Fields of papers citing papers by Sai Yendamuri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sai Yendamuri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sai Yendamuri. The network helps show where Sai Yendamuri may publish in the future.

Co-authorship network of co-authors of Sai Yendamuri

This figure shows the co-authorship network connecting the top 25 collaborators of Sai Yendamuri. A scholar is included among the top collaborators of Sai Yendamuri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sai Yendamuri. Sai Yendamuri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	415P: Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: Insights from the pembrolizumab 5-year global registry 2025 ·Journal of Thoracic Oncology ·Alessio Cortellini, (unknown), (unknown), (unknown), (unknown), Sai Yendamuri, Eleni Karapanagiotou, Raffaele Giusti, (unknown), Michael Rost, Gabriele Minuti, Marcello Tiseo, Luca Cantini, Giannis Mountzios, (unknown), (unknown), Ahmed Nassar, (unknown), Carla Caruso, Valerio Guarrasi	0
2	P2.11A.20 Metformin Enhances Immune Checkpoint Inhibitor Response in Overweight Lung Cancer Patients: A Retrospective Cohort Study 2024 ·Journal of Thoracic Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), Sai Yendamuri	1
3	Epidemiology and Survival of Malignant Central Airway Obstruction in Lung Cancer Identified on Cross-Sectional Imaging 2024 ·Journal of Bronchology & Interventional Pulmonology ·(unknown), (unknown), (unknown), (unknown), (unknown), Arjun Saradna, (unknown), (unknown), Sai Yendamuri, Han Yu, Gal Shafirstein, (unknown)	1
4	Correlation of Bronchoscopy and CT in Characterizing Malignant Central Airway Obstruction 2024 ·Cancers ·(unknown), Hafiz Muhammad Zubair, (unknown), (unknown), (unknown), (unknown), Arjun Saradna, (unknown), Gal Shafirstein, Sai Yendamuri, (unknown)	0
5	Adoption of the Robotic Platform across Thoracic Surgeries 2024 ·Journal of Clinical Medicine ·Kaity Tung, Sai Yendamuri, Kenneth P. Seastedt	3
6	Sex-based differences in the lung immune microenvironment are associated with an increased risk of lung cancer in women 2024 ·Journal of Thoracic and Cardiovascular Surgery ·Randall J. Smith, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Mary E. Reid, Joseph Barbi, Sai Yendamuri	2
7	Association between visceral obesity, metformin use, and recurrence risk in early-stage colorectal cancer 2023 ·Scientific Reports ·(unknown), Sarbajit Mukherjee, (unknown), Sai Yendamuri	4
8	Aging augments obesity-induced thymic involution and peripheral T cell exhaustion altering the “obesity paradox” 2023 ·Frontiers in Immunology ·(unknown), (unknown), Lam T. Khuat, Ziming Wang, (unknown), Ethan G. Aguilar, Kevin Stoffel, Sai Yendamuri, Randall J. Smith, Sarbajit Mukherjee, Joseph Barbi, Robert J. Canter, Arta M. Monjazeb, William J. Murphy	12
9	Sex-Specific Effects of Body Composition on Tumor Microenvironment in Non–Small Cell Lung Cancer 2023 ·Annals of Thoracic Surgery Short Reports ·(unknown), R. J. Seager, (unknown), Shuang Gao, Mary Nesline, Jeffrey M. Conroy, Grace K. Dy, Joseph Barbi, Sarabjot Pabla, Sai Yendamuri	0
10	Geographical Disparities in Esophageal Cancer Incidence and Mortality in the United States 2023 ·Healthcare ·(unknown), Navpreet Rana, Adrienne Groman, (unknown), Sai Yendamuri, Sarbajit Mukherjee	1
11	EP02.04-07 Metformin Enhances Immune Checkpoint Inhibitor Efficacy in an Obesity-Specific Manner 2023 ·Journal of Thoracic Oncology ·Sai Yendamuri, Randall J. Smith, Donna L. Washington, Joseph Barbi	2
12	Robotic versus thoraco-laparoscopic minimally invasive Ivor Lewis esophagectomy, a matched-pair single-center cohort analysis 2022 ·Diseases of the Esophagus ·Konstantinos Chouliaras, Kristopher Attwood, (unknown), Hideo Takahashi, (unknown), Sai Yendamuri, Todd L. Demmy, Steven N. Hochwald, Moshim Kukar	9
13	Quality of Life After Stereotactic Body Radiation Therapy or Surgery for Early-Stage NSCLC: A Systematic Review 2022 ·JTO Clinical and Research Reports ·Austin J. Iovoli, (unknown), Sung Jun, Mark Farrugia, (unknown), Sai Yendamuri, (unknown), Anurag K. Singh	7
14	Exceeding Radiation Dose to Volume Parameters for the Proximal Airways with Stereotactic Body Radiation Therapy Is More Likely for Ultracentral Lung Tumors and Associated with Worse Outcome 2021 ·Cancers ·Mark Farrugia, Sung Jun, Mark Hennon, Chukwumere Nwogu, Elisabeth U. Dexter, Anthony Picone, Todd L. Demmy, Sai Yendamuri, Han Yu, Simon Fung-Kee-Fung, (unknown), Anurag K. Singh, H Malhotra	15
15	Discordance of COVID‐19 guidelines for patients with cancer: A systematic review 2020 ·Journal of Surgical Oncology ·Pankaj Kumar Garg, (unknown), (unknown), Kiran K. Turaga, Mahendra Pal Singh, (unknown), Vipin Arora, Nishant Agrawal, (unknown), Sai Yendamuri	16
16	Pralatrexate in Combination with Oxaliplatin in Advanced Esophagogastric Cancer: A Phase II Trial with Predictive Molecular Correlates 2019 ·Molecular Cancer Therapeutics ·Usha Malhotra, Sarbajit Mukherjee, Christos Fountzilas, Patrick M. Boland, Austin Miller, Santosh K. Patnaik, Kristopher Attwood, Sai Yendamuri, Araba A. Adjei, Eric Kannisto, Mateusz Opyrchal, Peter Bushunow, Peter Loud, Renuka Iyer, Nikhil I. Khushalani	5
17	Evaluation of MicroRNA Expression Profiles That May Predict Recurrence of Localized Stage I Non–Small Cell Lung Cancer after Surgical Resection 2009 ·Cancer Research ·Santosh K. Patnaik, Eric Kannisto, Steen Knudsen, Sai Yendamuri	207
18	Tumor Suppressor Functions of ARLTS1 in Lung Cancers 2007 ·Cancer Research ·Sai Yendamuri, Francesco Trapasso, Manuela Ferracin, Rossano Cesari, Cinzia Sevignani, Masayoshi Shimizu, Shashi Rattan, Tamotsu Kuroki, Kristoffel R. Dumon, Florencia Bullrich, Chang‐Gong Liu, Massimo Negrini, Noel N. Williams, Larry R. Kaiser, Carlo M. Croce, George A. Calin	13
19	Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in breast cancer cell lines. 2003 ·PubMed ·Cinzia Sevignani, George A. Calin, Rossano Cesari, Manuela Sarti, Hideshi Ishii, Sai Yendamuri, Andrea Vecchione, Francesco Trapasso, Carlo M. Croce	62
20	Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. 2003 ·PubMed ·Tamotsu Kuroki, Francesco Trapasso, Sai Yendamuri, Ayumi Matsuyama, Hansjüerg Alder, Masaki Mori, Carlo M. Croce	127

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact